A Lassa Fever Vaccine Trial in Adults and Children Residing in West Africa

NCT05868733 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

612

Enrollment

NETWORK

Sponsor class

Conditions

Lassa Fever

Interventions

DRUG: Day 1 Lower Dose (2×106 pfu)
DRUG: Day 1 Higher Dose (1×107 pfu)
DRUG: Placebo

Sponsor

International AIDS Vaccine Initiative

Collaborators

[object Object]